Overview
Description
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Healthcare Biopharmaceuticals Other Biopharmaceuticals Switzerland
Financials
Key metrics
| Market capitalisation, EUR | 271,414 m |
| EPS, EUR | 6.40 |
| P/B ratio | 6.4 |
| P/E ratio | 20.5 |
| Dividend yield | 3.01% |
Income statement (2025)
| Revenue, EUR | 48,443 m |
| Net income, EUR | 12,423 m |
| Profit margin | 25.64% |
What ETF is Novartis AG in?
There are 70 ETFs which contain Novartis AG. All of these ETFs are listed in the table below. The ETF with the largest weighting of Novartis AG is the Xtrackers Swiss Large Cap UCITS ETF 1D.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
